Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Sang

Showing results (381-390 of 427) with videos related to

Pageof 43
Sort By:
Annals of General Psychiatry|October 6, 2023
Safety and effectiveness of oral medium to high dose blonanserin in patients with schizophrenia: subgroup analysis from a prospective, multicenter, post-marketing surveillance study in mainland ChinaYuan Yang, Hongmin Ge, Xijin Wang, et al.
Kidney Research and Clinical Practice|April 14, 2026
Hypocalcemia as a nontraditional risk factor for cardiovascular events and all-cause din patients with chronic kidney disease: insights from the Korean Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD)Sang Heon Suh, Hong Sang Choi, Chang Seong Kim, et al.
BMC Psychiatry|February 22, 2023
Effectiveness and safety of blonanserin in young and middle-aged female patients with schizophrenia: data from a post-marketing surveillanceQijing Bo, Xijin Wang, Xuejun Liu, et al.
The Korean Journal of Parasitology|March 6, 2022
Four Times of Relapse of Plasmodium vivax Malaria Despite Primaquine Treatment in a Patient with Impaired Cytochrome P450 2D6 FunctionSungim Choi, Heun Choi, Seong Yeon Park, et al.
Journal of Korean Medical Science|April 12, 2022
Infectivity of Coronavirus Disease 2019: A Prospective Cohort Study in the Korean Metropolitan AreaHyeri Seok, Seungkwan Lim, Ji-Yeon Kim, et al.
Journal of Clinical Medicine|September 10, 2021
Persistent Resistant Hypertension Has Worse Renal Outcomes in Chronic Kidney Disease than that Resolved in Two Years: Results from the KNOW-CKD StudySu-Hyun Song, Young-Jin Kim, Hong-Sang Choi, et al.
International Neurourology Journal|July 6, 2022
Efficacy and Safety of DA-8010, a Novel M3 Antagonist, in Patients With Overactive Bladder: A Randomized, Double-Blind Phase 2 StudyHee Seo Son, Cheol Young Oh, Myung-Soo Choo, et al.
Nature Communications|July 30, 2014
NEDD4 ubiquitinates TRAF3 to promote CD40-mediated AKT activationDi-Feng Fang, Kun He, Na Wang, et al.
Infection & Chemotherapy|December 24, 2021
Clinical and Laboratory Factors Associated with Symptom Development in Asymptomatic COVID-19 Patients at the Time of DiagnosisHong Sang Oh, Joon Ho Kim, Myoung Lyeol Woo, et al.
Journal of Gastroenterology and Hepatology|September 16, 2011
Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized studyHong Sang Oh, Dong Ho Lee, Ji Yeon Seo, et al.
Pageof 43

Showing results (381-390 of 427) with videos related to

Sort By:
Pageof 43
Annals of General Psychiatry|October 6, 2023
Safety and effectiveness of oral medium to high dose blonanserin in patients with schizophrenia: subgroup analysis from a prospective, multicenter, post-marketing surveillance study in mainland ChinaYuan Yang, Hongmin Ge, Xijin Wang, et al.
Kidney Research and Clinical Practice|April 14, 2026
Hypocalcemia as a nontraditional risk factor for cardiovascular events and all-cause din patients with chronic kidney disease: insights from the Korean Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD)Sang Heon Suh, Hong Sang Choi, Chang Seong Kim, et al.
BMC Psychiatry|February 22, 2023
Effectiveness and safety of blonanserin in young and middle-aged female patients with schizophrenia: data from a post-marketing surveillanceQijing Bo, Xijin Wang, Xuejun Liu, et al.
The Korean Journal of Parasitology|March 6, 2022
Four Times of Relapse of Plasmodium vivax Malaria Despite Primaquine Treatment in a Patient with Impaired Cytochrome P450 2D6 FunctionSungim Choi, Heun Choi, Seong Yeon Park, et al.
Journal of Korean Medical Science|April 12, 2022
Infectivity of Coronavirus Disease 2019: A Prospective Cohort Study in the Korean Metropolitan AreaHyeri Seok, Seungkwan Lim, Ji-Yeon Kim, et al.
Journal of Clinical Medicine|September 10, 2021
Persistent Resistant Hypertension Has Worse Renal Outcomes in Chronic Kidney Disease than that Resolved in Two Years: Results from the KNOW-CKD StudySu-Hyun Song, Young-Jin Kim, Hong-Sang Choi, et al.
International Neurourology Journal|July 6, 2022
Efficacy and Safety of DA-8010, a Novel M3 Antagonist, in Patients With Overactive Bladder: A Randomized, Double-Blind Phase 2 StudyHee Seo Son, Cheol Young Oh, Myung-Soo Choo, et al.
Nature Communications|July 30, 2014
NEDD4 ubiquitinates TRAF3 to promote CD40-mediated AKT activationDi-Feng Fang, Kun He, Na Wang, et al.
Infection & Chemotherapy|December 24, 2021
Clinical and Laboratory Factors Associated with Symptom Development in Asymptomatic COVID-19 Patients at the Time of DiagnosisHong Sang Oh, Joon Ho Kim, Myoung Lyeol Woo, et al.
Journal of Gastroenterology and Hepatology|September 16, 2011
Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized studyHong Sang Oh, Dong Ho Lee, Ji Yeon Seo, et al.
Pageof 43